CTOs on the Move

EMINENT Services Corporation

www.emiserv.com

 
EMINENT Services Corporation is a Frederick, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.emiserv.com
  • 7495 New Technology Way
    Frederick, MD USA 21703
  • Phone: 240.629.1972

Executives

Name Title Contact Details

Similar Companies

Care New England Health System (CNE)

Care New England Health System (CNE) is a Providence, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Inland Imaging Svc

Inland Imaging Svc is a Grand Terrace, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Willow Crest Hospital

It is the vision of Willow Crest hospital to be the provider of choice for patients, family members, and referral sources. We shall strive to exceed expectations of our customers in the provision of high quality, cost effective services.

Carotech

Carotech is a Edison, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.